# The Human Medicines (Amendment) Regulations 2019, Regulation 3: Amendment of regulation 8 (general interpretation)


In regulation 8(1) at the appropriate places insert—
““care home”—
(a) in relation to England, has the meaning given by section 3 of the Care Standards Act 2000;
(b) in relation to Wales, has the meaning given by paragraph 1 of Schedule 1 to the Regulation and Inspection of Social Care (Wales) Act 2016;
(c) in relation to Scotland, has the meaning given by paragraph 2 of Schedule 12 to the Public Services Reform (Scotland) Act 2010; and
(d) in relation to Northern Ireland, means a nursing home as defined in article 11 of the Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003;”;
““Commission Regulation 2016/161” means Commission Delegated Regulation (EU) 2016/161 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use;”;
““healthcare institution” has the meaning given by Article 3(2) of Commission Regulation 2016/161;”;
““hospice” means an institution whose primary function is the provision of palliative care to persons resident there who are suffering from a progressive disease in its final stages;”.

---
Source: https://www.legislation.gov.uk/uksi/2019/62/regulation/3 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.